Erich-Platzer-Portrait-Detail

Dr. Erich Platzer


Healthcare Partner and Member of the Board of Directors

Dr. Erich Platzer

Dr.
Erich Platzer

Healthcare Partner and Member of the Board of Directors

Erich Platzer is a Healthcare Partner as well as a member of the MTIP Board and will actively involve in the selection and evaluation of investment opportunities for the MTIP portfolio.

Dr. Platzer is active since 2010 as a Business Angel, with Lead Investor roles in multiple investments. Since 2001 until present, he is also an Investment Advisor and co-founder of Venture Capital company, HBM BioVentures, now named HBM Healthcare Investments. In those capacities, Dr. Platzer held multiple board roles including chairman in various biotech and medtech companies, public or private, US or Europe. Prior to that, 10 years of experience in product development and marketing at Roche, last as therapeutic area head of oncology, responsible for various strategic corporate partnerships. Prior, over 12 years in academic medicine and research; one of two co-founders and key members of the team at Memorial Sloan-Kettering Cancer Center (MSKCC) that purified human G-CSF in 1983 (recombinant: Neupogen®) with annual sales of USD 5+ billion (including its pegylated form). MD from the Medical School of the University of Erlangen, where he also received his ~MDPhD (German: Habilitation). Currently chairman of public company Probiodrug, as well as of private companies AOT, credentis and LMD (Léman Micro Devices); board member of Aptose Biosciences Inc (public) and Viroblock SA (private).